Chronic Disease News and Research

RSS

Advanced liver damage in hepatitis C patients grossly underestimated and underdiagnosed

The number of hepatitis C patients suffering from advanced liver damage may be grossly underestimated and underdiagnosed, according to a study led by researchers at Henry Ford Health System and the U.S. Centers for Disease Control and Prevention.

19 Aug 2015

Liraglutide drug combined with diet and exercise promotes weight loss in diabetic patients

Among overweight and obese patients with type 2 diabetes, daily injection of the diabetes drug liraglutide with a modified insulin pen device, in addition to diet and exercise, resulted in greater weight loss over 56 weeks compared with placebo, according to a study in the August 18 issue of JAMA.

19 Aug 2015

Intarcia Therapeutics announces positive top-line results from ITCA 650 Phase 3 FREEDOM-2 clinical trial

Intarcia Therapeutics, Inc. today announced positive top-line results from its 52-week Phase 3 FREEDOM-2 clinical trial to determine the comparative efficacy of the company's late-stage investigational candidate ITCA 650 to Merck's Januvia in reducing HbA1c in patients with type 2 diabetes following a year of treatment.

18 Aug 2015

Case Western Reserve awarded federal grant for nutritious food access study

The National Institutes of Health (NIH) has awarded $2.3 million to Case Western Reserve to lead a collaborative study of how changes in food options affect residents' nutritional choices and health over time.

11 Aug 2015

Study may lead to effective antimicrobial treatment strategies for people with uncontrolled diabetes

Case Western Reserve scientists may have uncovered a molecular mechanism that sets into motion dangerous infection in the feet and hands often occurring with uncontrolled diabetes. It appears that high blood sugar unleashes destructive molecules that interfere with the body's natural infection-control defenses.

7 Aug 2015

TWi Biotechnology gets notice of patent allowance covering use of AC-201 drug in diabetes treatment

TWi Biotechnology, Inc., today announced that it has received Notices of Allowance for AC-201, TWi Biotechnology's lead drug candidate, from the European Patent Office and the Patent Office of the Russian Federation for patent applications numbered 11766702.2-1460 and 2012147449, respectively.

3 Aug 2015

PHI model helps identify top health risks associated with chronic diseases

Public health agencies across the globe are challenged with preventing the spread of chronic diseases while dealing with limited funds and devastating budget cuts.

3 Aug 2015

Embracing new technologies to improve healthcare provision

A leading US pharmacy services provider and IT company have announced their collaboration to facilitate the provision of truly patient-centred primary care.

31 Jul 2015

IBM, CVS Health to transform care management services for patients with chronic disease

CVS Health (NYSE: CVS) and IBM today announced they will use predictive analytics and Watson cognitive computing to transform care management services for patients with chronic disease.

30 Jul 2015

New research shows promising progress in use of anti-inflammatory cytokine for T1D treatment

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports (Nature Publishing Group), reveals that administration of interleukin-35 (a protein made by immune cells) to mice with type 1 diabetes, reverses or cures the disease by maintaining a normal blood glucose level and the immune tolerance.

30 Jul 2015

UT Southwestern's Pulmonary Hypertension Program continues to grow in the U.S.

When Derrik Neal began having trouble breathing, he initially assumed it was because he was overweight. But after blacking out several times, he learned he had idiopathic pulmonary hypertension. Survival rates at the time he was diagnosed were five years or less - three or less if undetected.

30 Jul 2015

IOF, EOS to jointly hold Middle East & Africa Osteoporosis Meeting in Abu Dhabi

With a growing senior population and an increase in unhealthy lifestyles, the prevalence of osteoporosis and Type 2 Diabetes Mellitus is soaring in the Middle East and North African region. In response to the dramatic increase in these diseases within the region the International Osteoporosis Foundation, in cooperation with the Emirates Osteoporosis Society, will be holding the 3rd Middle East & Africa Osteoporosis Meeting from December 5-7, 2015 in Abu Dhabi.

29 Jul 2015

Sedentary time not linked to poorer diets among US adults

Previously identified associations between TV viewing and a less healthful diet may stem from exposure to advertisements of high calorie foods and 'distracted eating' rather than the activity of sitting itself, although sitting time remains an independent risk factor requiring public health focus. These findings are according to a new study by American Cancer Society investigators conducted in collaboration with the Gretchen Swanson Center for Nutrition and the University of Texas School of Public Health.

17 Jul 2015

Majority of Canadians support inclusion of private drug plans in pan-Canadian pharmacare program

While a strong majority of Canadians support the concept of a pan-Canadian pharmacare program, they don't necessarily want it to replace their existing private prescription drug plans according to a national survey conducted as part of the Canadian Pharmacists Association's Pharmacare 2.0 Initiative.

16 Jul 2015

ESMO offers five-day medical oncology course for medical students

The European Society for Medical Oncology is offering a five-day medical oncology course for medical students in Valencia, Spain, in its latest venture to engage with the medical student community. The course aims to attract medical students to the medical oncology profession to ensure there are sufficient numbers to care for the rising numbers of cancer patients.

16 Jul 2015

COPD risk may occur during childhood and adolescence

Chronic obstructive pulmonary disease (COPD) is one of most common causes of death in the world today - active smoking accounting for approx. 85% of all cases. Yet ground-breaking research from the University of Copenhagen indicates that accelerated decline of lung function is not a prerequisite for COPD.

13 Jul 2015

Study discovers potential link between inherited genome-wide DNA sequences and CAD

A study to examine recessively inherited genome-wide DNA sequences has for the first time discovered a potential link with Britain's biggest killer - Coronary Artery Disease (CAD).

10 Jul 2015

LUX-Lung 8 supports afatinib in squamous NSCLC

Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.

8 Jul 2015

Rutgers' Martha Lansing named Family Physician of the Year by NJAFP

Martha Lansing, MD, associate professor and vice chair of family medicine and community health at Rutgers Robert Wood Johnson Medical School and a resident of Hopewell, NJ, has been named the Family Physician of the Year by the New Jersey Academy of Family Physicians.

8 Jul 2015

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston School of Public Health.

6 Jul 2015

Chronic Disease News and Research

Advanced liver damage in hepatitis C patients grossly underestimated and underdiagnosed

Liraglutide drug combined with diet and exercise promotes weight loss in diabetic patients

Intarcia Therapeutics announces positive top-line results from ITCA 650 Phase 3 FREEDOM-2 clinical trial

Case Western Reserve awarded federal grant for nutritious food access study

Study may lead to effective antimicrobial treatment strategies for people with uncontrolled diabetes

TWi Biotechnology gets notice of patent allowance covering use of AC-201 drug in diabetes treatment

PHI model helps identify top health risks associated with chronic diseases

Embracing new technologies to improve healthcare provision

IBM, CVS Health to transform care management services for patients with chronic disease

New research shows promising progress in use of anti-inflammatory cytokine for T1D treatment

UT Southwestern's Pulmonary Hypertension Program continues to grow in the U.S.

IOF, EOS to jointly hold Middle East & Africa Osteoporosis Meeting in Abu Dhabi

Sedentary time not linked to poorer diets among US adults

Majority of Canadians support inclusion of private drug plans in pan-Canadian pharmacare program

ESMO offers five-day medical oncology course for medical students

COPD risk may occur during childhood and adolescence

Study discovers potential link between inherited genome-wide DNA sequences and CAD

LUX-Lung 8 supports afatinib in squamous NSCLC

Rutgers' Martha Lansing named Family Physician of the Year by NJAFP

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News